In addition, Long et al pointed out that ADI drug-resistant cell lines of melanoma, the expression of lactate dehydrogenase A and glucose transporter 1 was increased, while the expression of pyruvate dehydrogenase was decreased, indicating the glycolytic pathway was activated [24]. The gene discussed is LDHA; the disease is melanoma.